Viewing Study NCT03470233


Ignite Creation Date: 2025-12-25 @ 2:53 AM
Ignite Modification Date: 2025-12-26 @ 1:34 AM
Study NCT ID: NCT03470233
Status: COMPLETED
Last Update Posted: 2021-09-17
First Post: 2018-02-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module